UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048406
Receipt No. R000055177
Scientific Title Usefulness of endoscopic ultrasound-guided fine needle biopsy in tissue collection for precision medicine-multicenter retrospective cohort study-
Date of disclosure of the study information 2022/07/20
Last modified on 2022/07/19 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Usefulness of endoscopic ultrasound-guided fine needle biopsy in tissue collection for precision medicine-multicenter retrospective cohort study-
Acronym Usefulness of EUS-FNB in precision medicine
Scientific Title Usefulness of endoscopic ultrasound-guided fine needle biopsy in tissue collection for precision medicine-multicenter retrospective cohort study-
Scientific Title:Acronym Usefulness of EUS-FNB in precision medicine
Region
Japan

Condition
Condition Pancreatic cancer
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To clarify the success rate of cancer gene panel test using EUS-FNB samples in real world.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Success rate of cancer gene panel test using EUS-FNA specimens
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Cases that have been pathologically diagnosed as unresectable pancreatic cancer

2)Cases scheduled for cancer gene panel testing using EUS-FNA specimens
Key exclusion criteria 1) Cases refused to participate in this study

2) Cases that have been registered once in this study
Target sample size 300

Research contact person
Name of lead principal investigator
1st name REIKO
Middle name
Last name ASHIDA
Organization Wakayama medical university
Division name Second Department of Internal Medicine
Zip code 6418509
Address 811-1 Kimiidera, Wakayama City
TEL 073-447-2300
Email rashida@wakayama-med.ac.jp

Public contact
Name of contact person
1st name REIKO
Middle name
Last name ASHIDA
Organization Wakayama Medical University
Division name Second Department of Internal Medicine
Zip code 6418509
Address 811-1 Kimiidera, Wakayama City
TEL 073-447-2300
Homepage URL
Email ninai@wakayama-med.ac.jp

Sponsor
Institute Wakayama Medical University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Research Ethics Committee of Wakayama Medical University
Address 811-1 Kimiidera, Wakayama City
Tel 073-447-2300/+81-73-447-2300
Email wa-rinri@wakayama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 07 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 06 Month 21 Day
Date of IRB
2022 Year 06 Month 21 Day
Anticipated trial start date
2022 Year 08 Month 01 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2022 Year 07 Month 19 Day
Last modified on
2022 Year 07 Month 19 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055177